301258.SZ
Suzhou Fushilai Pharmaceutical Co., Ltd.
SZSE · C 制造业 · CN
CNY 26.06
−1.62%Margins
Gross margin
16.8%
EBITDA margin
30.4%
EBIT margin
11.0%
Net margin
9.1%
FCF margin
-31.4%
2.0%
Return on equity
1.8%
Return on assets
2.4%
Return on invested capital
0.20x
Asset turnover
CNY 36.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026